MC

Milenko Cicmil

Partner at Cure Ventures

Boston, Massachusetts

Overview

Work Experience

  • Visiting Research Fellow at Univ. of Reading, UK

    2020 - Current

  • Partner

    2021

  • Chairman Of The Board AMP Discovery

    2021 - 2022

  • Vice President Global Head of external Innovation

    2019 - 2021

  • Vice President - Translational Biology

    2017 - 2019

  • Director at Merck Innovation Hub

    2016 - 2017

  • Director Pharmacology Immuno-Oncology and Immunomodulation

    2013 - 2016

  • Director In vivo Pharmacology R&I

    2011 - 2013

  • Group Leader Integrative Pharmacology Discovery Bioscience - Inflammation

    2007 - 2011

  • Senior Research Scientist

    2004 - 2007

  • Senior Research Scientist

    2002 - 2004

  • Translational Science - Research Fellow

    2000 - 2002

Relevant Websites